NASDAQ:MBRX | Free Cash Flow | Moleculin Biotech, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.11M
2025-12-31-$5.37M$0.00-$5.37M-34.50%
2025-03-31-$4.56M$0.00-$4.56M
2024-12-31-$5.08M$0.00-$5.08M
2024-03-31-$6.72M$0.00-$6.72M
2023-12-31-$4.9M$81,000.00-$4.98M
2023-03-31-$6.02M$0.00-$6.02M
2022-12-31-$7.26M$0.00-$7.26M
2022-03-31-$4.81M$6,000.00-$4.81M
2021-12-31-$4.26M$19,000.00-$4.28M
2021-03-31-$3.62M$0.00-$3.62M
2020-12-31-$3.12M$16,000.00-$3.14M
2020-03-31-$4.34M$2,000.00-$4.34M
2019-12-31-$4.68M$10,000.00-$4.69M
2019-03-31-$3.85M$15,000.00-$3.86M
2018-12-31-$3.11M$114,000.00-$3.22M
2018-03-31-$2.81M$8,000.00-$2.82M
2017-12-31-$2.39M$16,000.00-$2.41M
2017-03-31-$1.39M$0.00-$1.39M
2016-12-31-$1.17M$11,000.00-$1.18M
2016-03-31-$290,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$22.74M$0.00-$22.74M
2024-12-31-$23.86M$13,000.00-$23.88M
2023-12-31-$23.59M$124,000.00-$23.72M
2022-12-31-$27.64M$67,000.00-$27.71M
2021-12-31-$18.95M$19,000.00-$18.97M
2020-12-31-$17.77M$376,000.00-$18.15M
2019-12-31-$17.2M$52,000.00-$17.25M
2018-12-31-$12.2M$417,000.00-$12.62M
2017-12-31-$7.32M$28,000.00-$7.35M
2016-12-31-$3.77M$21,000.00-$3.79M